![Ashoo Gupta](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 466 315 $ al 31/05/2026
Ashoo Gupta is Controller & Vice President-Finance at 4D Molecular Therapeutics, Inc. since 2026.
Formerly, Mr. Gupta was Vice President-Finance & Controller at Kyverna Therapeutics, Inc. from 2023 to 2024.
Mr. Gupta completed undergraduate education at the University of Mumbai.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 20/03/2026 | 47.055 ( 0,09 % ) | 466 315 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| 4D MOLECULAR THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/06/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| KYVERNA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/06/2024 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
University of Mumbai
 University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
4D Molecular Therapeutics, Inc.
 4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
Kyverna Therapeutics, Inc.
 Kyverna Therapeutics, Inc. BiotechnologyHealth Technology Operates as a cell therapy company which develops treatments and potential cures for serious autoimmune diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
